SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-11-100704
Filing Date
2011-11-28
Accepted
2011-11-28 16:27:35
Documents
6
Period of Report
2011-11-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K b89285e8vk.htm 8-K 14316
2 EX-4.1 b89285exv4w1.htm EX-4.1 8171
3 EX-10.1 b89285exv10w1.htm EX-10.1 133781
4 EX-10.2 b89285exv10w2.htm EX-10.2 64866
5 EX-99.1 b89285exv99w1.htm EX-99.1 6820
6 GRAPHIC b89285b8928500.gif GRAPHIC 2997
  Complete submission text file 0000950123-11-100704.txt   233403
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 111228658
SIC: 2836 Biological Products, (No Diagnostic Substances)